Rees Andrew sold 17,251 shares of Crocs, Inc. at $153.28 for −$2.64M on Nov 3, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Executive Officer
Chief Executive Officer
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$2,644,202.23Shares × reported price
Shares traded
17,251Common Stock
Price per share
$153.28Reported price. Read footnotes for ranges.
% of reported position traded
2.48%This security and ownership context
Holdings after
677,993Indirect · By Trust
Trade date
Nov 3, 2026Sell
Filed
Nov 5, 2026, 4:37 PM ET2-day reporting delay
Accession
0001609901-26-000017Code S · Transaction 393627
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 695,244 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 3, 2026Sell18,049$152.25−$2,747,870.01Trade 393626
Nov 3, 2026Sell4,700$153.94−$723,523.17Trade 393628
3 transaction rows in this filing. Joint filers share the same rows.

CROX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CROX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −23%1w ago −22%1d ago −22%
Returns since7d +2.6%30d90d180d1y

Footnotes in full

F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.67 - $152.66, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes. F2: The reporting person is a trustee of the REES FAMILY LIVING TRUST U/A DTD 03/22/2019 and exercises voting and investment power for the shares beneficially owned by the trust. F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.67 to $153.57, inclusive. F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.78 to $154.08, inclusive.